STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

NEPH NEPHROS INCORPORATED StockScouter® Report

3

StockScouter® Score

NEPHROS INCORPORATED, a micro cap growth company in the capital goods sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The 50-day moving average for NEPH is above its 200-day moving average. Positive

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, growth stocks will be neutral, and capital goods stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

F
N/A
F
C

Previous Ratings

2
3